SIGA Technologies, Inc. Files for Chapter 11 Reorganization - Market...

09/16/14


The Pharma Letter

SIGA Technologies, Inc. Files for Chapter 11 Reorganization
MarketWatch
SIGA commenced the chapter 11 case to preserve and to assure its ability to satisfy its commitment to supply Tecovirimat, an antiviral smallpox drug being delivered to the U.S. Strategic National Stockpile under the Project BioShield Act of 2004. SIGA ...
PharmAthene Plunges After Siga Technologies Files For Chapter 11 BankruptcyBidness ETC
Siga Technologies Files for Bankruptcy ProtectionWall Street Journal
Smallpox Drug Maker Files Bankruptcy to Fight Court LossBusinessweek
MSN Money
all 23 news articles »

[more]